Pandemia: How Coronavirus Hysteria Took Over Our Government, Rights, and Lives

“Report: Aspirin Taken Daily with Bottle of Bourbon Reduces Awareness of Heart Attacks,” The Onion, June 10, 1998, https://www.theonion.com/report-aspirin-taken-daily-with-bottle-of-bourbon-redu-1819564746.

The speed with which the White House moved was the surest signal yet that the Biden administration understood how quickly the vaccines were failing.

Almost two years into the crisis, we have not just failed to find really effective new small-molecule drug treatments for Covid, we do not even know if a long list of cheap drugs that are already widely available might help.

The fact that supposedly reputable news organizations are openly working in concert with governments to craft narratives around Covid—and now to push vaccines and demonize the unvaccinated—is extraordinarily dangerous. And the fact that Twitter banned me at the open urging of the federal government is a betrayal of American values that is hard to b

By July and August, I had grown more concerned about the vaccines than ever. Alongside their declining effectiveness and the data showing the superiority of natural immunity, their “tail risks” appeared to be rising.

This strategy was essentially untested. Neither Pfizer nor Moderna had run placebo-controlled trials on boosters. In fact, at the time Israel began its booster program, the publicly available data about a third dose covered a few dozen people. Boosters clearly provided a short-term increase in antibodies against the spike protein. But no one knew h

For vaccines, two tail risks were clear. The first was a Marek’s disease–leaky vaccine scenario in which the vaccinated would become dangerous to the unvaccinated. The second was antibody dependent enhancement, or ADE, the true horror, in which the shots would not just fail but actually increase the dangers of new variants for the vaccinated.

Already, a strong argument can be made that the vaccines are extending the pandemic.

Monoclonal antibodies do work, and pharmaceutical companies deserve credit for developing those—but they are expensive and difficult to produce, and thus hard to scale widely even in the United States, much less across the world.)